Frontlight ResearchEarly access
Trial site
Tasman Oncology Research
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Melanoma7 trials
- Lung cancer4 trials
- Bladder cancer3 trials
- Cervical cancer3 trials
- Colorectal cancer3 trials
- Gastric and oesophageal cancer3 trials
- Liver and biliary tract cancer3 trials
- Prostate cancer3 trials
- Head and neck cancer2 trials
- Kidney cancer2 trials
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- and 7 more
- Phase
- Phase 15 trials
- Phase 33 trials
- Phase 1/22 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting3 trials
- Terminated2 trials
- Lead sponsor
- Amgen2 trials
- OncoC4, Inc.2 trials
- Adze Biotechnology Australia Pty Ltd1 trial
- Bristol-Myers Squibb1 trial
- Eli Lilly and Company1 trial
- and 5 more
Running trials
Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Recruiting
A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma
Active, not recruiting
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma3 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
Completed
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026